Hereditary spastic paraparesis (HSP) is a group of neurological diseases characterized by progressive impairment of lower limb movement due to muscle spasticity. This disease is associated with damage to the corticospinal tracts, which leads to increased muscle tone and limited motor activity. Spastic paraparesis can be expressed in various forms of severity and can manifest in childhood, but its manifestations often become more obvious at the age of 20-30 years, when the need for physical effort increases.
History of the disease and interesting historical facts
Hereditary spastic paraparesis was first described in the 19th century, when a link between clinical symptoms and genetic predisposition was identified. Historical research shows that descriptions of paraparesis can be found in the works of Hippocrates, although there was no knowledge of its hereditary nature at that time.
Some of the most significant advances in understanding the disease were made in the early 20th century, when doctors began to differentiate it from other forms of paralysis. In the 1980s, advances in molecular genetics made it possible to detail the genetic changes associated with NSP, opening up new horizons in diagnosis and treatment of the disease.
Epidemiology
Studies show that hereditary spastic paraparesis occurs with a frequency of about 1-2 cases per 100,000 population. This disease has characteristic manifestations that can vary significantly depending on the population and region, but a well-established genetic predisposition makes it more common among certain family groups.
Genetic predisposition to this disease
Hereditary spastic paraparesis is caused by mutations in various genes, including SPG4, SPG11, and SPG7. These genes are responsible for functions related to neuronal survival and myelination. For example, mutations in the SPAST gene (SPG4) are the most common cause leading to the spastic paraparesis form of the disease. Inheritance is either autosomal dominant or autosomal recessive, highlighting the importance of genetic counseling for family members with a history of the disease.
Risk factors for the development of this disease
Risk factors that contribute to the development of hereditary spastic paraparesis include:
- Heredity: presence of cases of the disease in the family.
- Genetic mutations: Certain genetic changes may increase your risk.
- Environmental Impact: Certain Chemicals and Toxins.
- Bad habits: Smoking and drinking alcohol during pregnancy can increase the risks.
Diagnosis of this disease
A variety of methods are used to diagnose hereditary spastic paraparesis, including:
- Clinical assessment: testing for spasticity, reflexes and muscle strength.
- Laboratory tests: Blood tests for markers associated with genetic syndromes.
- Radiological examinations: magnetic resonance imaging to detect structural changes in the brain.
- Genetic testing: DNA sequencing to identify mutations that cause disease.
- Differential diagnosis: exclude other causes of spasticity, such as multiple sclerosis and cerebral palsy.
Treatment
Treatment for hereditary spastic paraparesis includes:
- General treatment: rehabilitation measures, physical therapy to improve functional capabilities.
- Pharmacological treatment: use of muscle relaxants and antispasmodics.
- Surgical treatment: In selected cases, surgery may be considered to reduce spasticity.
- Other types of treatment: sessions with speech therapists and psychologists to improve quality of life.
List of medications used to treat this disease
The main medications used for treatment include:
- Baclofen
- Tizanidin
- Dantrolene
- Benzodiazepines
- Cannabinoids
Disease monitoring
Monitoring of hereditary spastic paraparesis includes:
- Regular check-ups to assess disease progression and adjust treatment.
- Monitoring of functional status and development of complications such as contractures or infections.
- Assessing the prognosis based on the extent of the lesion and response to therapy.
- Development of an individual medical care plan depending on the patient's condition.
Age-related features of the disease
In adults, the disease may present with more pronounced spasticity and weakness, while in children the symptoms are often less pronounced but require early intervention to optimize functional status. In older patients, progression may be complicated by comorbidities, which requires an individual approach to treatment.
Questions and Answers
- What are the main symptoms of hereditary spastic paraparesis?
Symptoms include weakness in the legs, spasticity, difficulty walking and loss of coordination. - How is the disease diagnosed?
Diagnosis includes clinical evaluation, genetic testing, MRI, and other methods aimed at ruling out other diseases. - Can hereditary spastic paraparesis be prevented?
It is not possible to completely prevent the disease, but genetic counseling can help assess the risks for families. - What is the treatment for hereditary spastic paraparesis?
Treatment includes physical rehabilitation, medications to relieve spasticity, and in some cases surgery. - What is the life expectancy of patients with this diagnosis?
Life expectancy varies depending on the severity of the disease and the presence of comorbidities, but many patients have a normal life expectancy.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends paying attention to the dynamics of the condition and being attentive to symptoms. “It is important for each patient to cooperate with the medical team and actively participate in rehabilitation programs to maintain quality of life.” He also emphasizes the need for regular monitoring of the condition and adaptation of treatment based on changes in symptoms.
